Zydus Cadila launches COPD drug in India
Zydus Cadila is launching Forglyn pMDI, pressurised Metered Dose Inhaler (pMDI) with a combination of Long Acting Muscarinic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COPD
GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD
AstraZeneca eyes three-drug inhaler opportunity after trial results
AstraZeneca said that the ETHOS trial of triple-drug therapy c formerly known as PT010, helped patients suffering from chronic…
Lupin ties up with Omron Healthcare
To strengthen respiratory disease management facilities Medical device maker Omron Healthcare India has joined hands with…
Glenmark launches triple therapy inhaler
AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population
Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL
Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials are indicated for the long-term maintenance…
US FDA grants orphan drug status to AstraZeneca’s asthma drug Fasenra
EoE, also known as allergic oesophagitis, is an allergic inflammation of the esophagus that involves a form of white blood cell,…
Glenmark to partner with Novartis to market three respiratory products in Brazil
This arrangement will strengthen Glenmark's respiratory franchise in Brazil Novartis will be responsible to manufacture the…
AstraZeneca boosts respiratory unit with $575 million Takeda deal
The company will spend $800 million to expand its presence in China AstraZeneca has agreed to buy Takeda Pharmaceutical's…